-+ 0.00%
-+ 0.00%
-+ 0.00%

Opus Genetics enters senior secured note deal for up to $155 million

PUBT·04/24/2026 21:08:57
Listen to the news
Opus Genetics enters senior secured note deal for up to $155 million
  • Opus Genetics entered senior secured note purchase agreement with OPCM SA LLC as purchaser agent for issuance of up to USD 155 million of senior secured notes.
  • Purchasers committed to buy USD 105 million, leaving USD 50 million uncommitted.
  • Initial tranche of USD 35 million funded April 21, 2026, with notes issued at par.
  • Initial Tranche Notes mature April 21, 2033, with floating interest tied to Term SOFR subject to floor.
  • Notes secured by substantially all assets of Opus Genetics and subsidiaries, with guarantees from certain subsidiaries.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Opus Genetics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001140361-26-016764), on April 24, 2026, and is solely responsible for the information contained therein.